在大肠炎中,STAT1调解了英5的促炎作用
Yichen Li1,2,3, Wenxia Wang1,3,4, Ruixin Zhu5
1Department of Immunology and Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
Communications biology
|March 7, 2025
概括
关酸结合蛋白5 (GBP5) 通过提高STAT1活性来增强炎症性肠病 (IBD). 损失5英减少了炎症和先天性淋巴细胞,突出了5英.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 胃肠病学 胃肠病学
背景情况:
- 关酸结合蛋白5 (GBP5) 被认为是炎症性肠病 (IBD) 病原发生的关键因素.
- 确切的分子机制,通过GBP5有助于肠道炎症仍然不完全理解.
研究的目的:
- 阐明在炎症性肠病 (IBD) 背景下,酸结合蛋白5 (GBP5) 促进炎症的特定机制.
- 在实验性结肠炎模型中研究GBP5,STAT1激活和先天性淋巴细胞 (ILCs) 的扩张之间的关系.
主要方法:
- 利用大肠炎的小鼠模型来评估Gbp5缺乏对结肠炎症和先天性淋巴细胞群的影响.
- 分析了GBP5缺少的THP-1细胞的转录变化,并将它们与STAT1激活的个人资料进行了比较.
- 研究了GBP5和STAT1之间的相互作用,包括其在STAT1核转移和下游基因表达中的作用.
主要成果:
- 在患有大肠炎的小鼠中,Gbp5的损失显著降低了结肠炎症,并减少了先天性淋巴细胞 (ILC) 的数量.
- 发现,GBP5对于刺激STAT1的表达及其促炎下游因子,包括细胞因子,至关重要.
- GBP5促进STAT1核转移,增强STAT1表达和其向基因的表达,从而促进炎症.
结论:
- 关酸结合蛋白5 (GBP5) 通过增强STAT1.1的活性和表达,在炎症性肠病 (IBD) 中起着关键的促炎作用.
- GBP5的机制涉及促进STAT1核转移,导致增加STAT1依赖性细胞因子的产生,推动先天性淋巴细胞扩张并加剧结肠炎.
相关概念视频
Inflammatory Response
1.7K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.7K
Inflammatory Bowel Disease I: Ulcerative Colitis
108
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
108
Drugs for Treatment of Ulcerative Colitis in IBD
116
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
116
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
107
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
107
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
291
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
291
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K


